If Lab-Products Industry Were Like the Game of Risk, Radnor’s VWR Would Be Dominating

Ongoing experiments to find a buyer for Radnor lab supplier VWR have finally produced a proposed $6.4 billion sale to Avantor.

Radnor-based laboratory products and equipment supplier VWR is maintaining its “growth by acquisition” strategy by making its sixth purchase in less than two years, writes John George for the Philadelphia Business Journal.

VWR has acquired PAW BioSciences Products, a manufacturer and distributor of products for sanitary-fluid handling used in the biotechnology, biopharmaceutical, and diagnostic industries. VWR has not disclosed the financial terms of the deal.

Based in New Jersey, PAW was founded 16 years ago and focuses its business operations on custom-designed, single-use connectors and components. It also provides assembly and product distribution systems to support cell culture and purification processes.

Manuel Brocke-Benz, President and CEO of VWR, said that having PAW as part of the company will complement its existing single-use product and service offerings.

Earlier this year, the company purchased Therapak Corp, Therapak Pharma Services Ltd., and JM Separations.

With these three companies, VWR has already equaled the number of companies that it purchased in 2015, as it continues its growth-by-acquisition strategy.

Read more about VWR in the Philadelphia Business Journal by clicking here.

Join Our Community

Never miss a Delaware County story!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.